Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,551 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The EORTC QLU-C10D: the Hong Kong valuation study.
Xu RH, Wong EL, Luo N, Norman R, Lehmann J, Holzner B, King MT, Kemmler G; EORTC QLG. Xu RH, et al. Among authors: luo n. Eur J Health Econ. 2023 Sep 28. doi: 10.1007/s10198-023-01632-4. Online ahead of print. Eur J Health Econ. 2023. PMID: 37768519
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.
Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, Mauskopf J, Mullins CD, Petrou S, Pwu RF, Staniszewska S; CHEERS 2022 ISPOR Good Research Practices Task Force. Husereau D, et al. Eur J Health Econ. 2022 Nov;23(8):1309-1317. doi: 10.1007/s10198-021-01426-6. Epub 2022 Jan 27. Eur J Health Econ. 2022. PMID: 35084632 Free PMC article.
Author Reply.
Brazier J, Peasgood T, Mukuria C, Luo N, Mulhern B, Pickard AS, Augustovski F, Greiner W, Engel L. Brazier J, et al. Among authors: luo n. Value Health. 2023 Mar;26(3):437-440. doi: 10.1016/j.jval.2022.10.010. Epub 2022 Nov 11. Value Health. 2023. PMID: 36372299 Free article. No abstract available.
Mechanistic Characterization of Cancer Associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein.
Gallant JP, Hintz HM, Gunaratne GS, Breneman MT, Recchia EE, West JL, Ott KL, Heninger E, Jackson AE, Luo NY, Rosenkrans ZT, Hernandez R, Zhao SG, Lang JM, Meimetis L, Kosoff D, LeBeau AM. Gallant JP, et al. Among authors: luo ny. Cancer Res Commun. 2024 May 15. doi: 10.1158/2767-9764.CRC-24-0248. Online ahead of print. Cancer Res Commun. 2024. PMID: 38747612
1,551 results